Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 409-420 of 1,136
Drug study icon
CompletedNCT04513912

Seltorexant Compared to Quetiapine XR for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing Seltorexant Compared to Quetiapine XR for depression.

In Canada
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT00550238

Safety study of pimavanserin in Schizophrenia

This study is completed in the United States, in France, in Canada, .... It is testing pimavanserin for Schizophrenia.

In Canada
SchizophreniaDrugOver 40 Years
Countries
United States, France, Canada, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04693351

Troriluzole for OCD

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.

In Canada
OCDDrugFrom 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Drug study icon
CompletedNCT02417064

Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in Canada, .... It is testing efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In Canada
DepressionDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Device study icon
CompletedNCT01290991

Safety of Augment™ Bone Graft

This study is completed in Canada. It focuses on OCD.

In Canada
OCDDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 40 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
OCD
Drug study icon
CompletedNCT03893825

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

This study exists to understand how the medication TV-46000 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication TV-46000 can better prevent setbacks and support longer-term stability.

In Canada
SchizophreniaDrugFrom 13 Years to 65 Years
Countries
United States, France, Canada, ...
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.